Is the Party Over for Best-Selling Drug Humira?

The Journal.

The Wall Street Journal

News, Daily News, Business News

4.2 • 5.8K Ratings

🗓️ 9 February 2023

⏱️ 17 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

After decades of patent protection, the wildly successful arthritis and autoimmune drug Humira is finally facing competition. WSJ’s Jared Hopkins on what that could mean for patients and the drug industry. Further Reading: - Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S. - AbbVie Aims for New Drugs to Boost Sales as Competitors Target Humira Further Listening: - How Big Pharma Lost Its Swagger Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	What's the most popular drug in the world right now?
0:09.0	Are you trying to get me to say that it is Aviv's Humira?
0:13.0	Okay, let's start again.
0:15.0	Yeah, I think you should.
0:16.0	Okay, but before we do, is it Humira or Humira or Humira?
0:23.0	How should we say it?
0:24.0	Should I pull up an ad real quick from Aviv and then we would know?
0:27.0	Yeah.
0:28.0	If you have moderate to severe rheumatoid arthritis and you're talking to your doctor about your medication, this is Humira.
0:35.0	This is...
0:36.0	Humira, it's Humira. I just... I just... Humira.
0:39.0	Okay.
0:42.0	Our colleague Jared Hopkins covers the drug market and that includes what has been, at least until the COVID vaccine, the world's best-selling drug.
0:51.0	In normal times, Humira was king.
0:54.0	What made it king? What's so great about it?
0:56.0	It is a highly effective drug and it's approved to treat arthritis and a number of other autoimmune diseases that are sort of debilitating for millions of people.
1:11.0	How much does it cost?
1:14.0	At the moment, an annual list price is about $90,000.
1:20.0	Wow.
1:21.0	Yeah.
1:23.0	And that high cost has drawn a lot of criticism.
1:27.0	I think what's captured a lot of people's sort of attention is the idea that this hugely successful and widely used drug has not had any competition from cheaper products.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.